Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julianne D Jett

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2012
Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognitionJulianne D Jett, David A Morilak
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2010
Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortexCorina O Bondi, Julianne D Jett, David A Morilak
Neuroscience|January 30, 2017
Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortexJulianne D Jett, Sarah E Bulin, Lauren C Hatherall, et al.
Journal of Visualized Experiments : Jove|March 6, 2015
The attentional set shifting task: a measure of cognitive flexibility in miceJillian M Heisler, Juan Morales, Jennifer J Donegan, et al.
Psychopharmacology|May 20, 2015
Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathwayJulianne D Jett, Angela M Boley, Milena Girotti, et al.
Journal of Addiction Medicine|June 2, 2023
Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use DisorderJulianne D Jett, Gordon Kordas, Sara Parent, et al.
Alcohol, Clinical & Experimental Research|February 22, 2023
Validation of the quantification of phosphatidylethanol 16:0/18:1 concentrations in TASSO-M20 devicesJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.
The American Journal of Drug and Alcohol Abuse|January 29, 2024
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trialJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.
Journal of Consulting and Clinical Psychology|June 26, 2025
Testing adaptations to contingency management for alcohol use disorders: A randomized controlled trialMichael G McDonell, Sara Parent, Julianne D Jett, et al.
Drug and Alcohol Dependence Reports|October 21, 2024
Covid-19 vaccination status and beliefs of individuals with co-occurring serious mental illness and alcohol use disorderMohammad Keshtkar, Diana Tyutyunnyk, Paige King, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2012
Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognitionJulianne D Jett, David A Morilak
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2010
Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortexCorina O Bondi, Julianne D Jett, David A Morilak
Neuroscience|January 30, 2017
Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortexJulianne D Jett, Sarah E Bulin, Lauren C Hatherall, et al.
Journal of Visualized Experiments : Jove|March 6, 2015
The attentional set shifting task: a measure of cognitive flexibility in miceJillian M Heisler, Juan Morales, Jennifer J Donegan, et al.
Psychopharmacology|May 20, 2015
Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathwayJulianne D Jett, Angela M Boley, Milena Girotti, et al.
Journal of Addiction Medicine|June 2, 2023
Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use DisorderJulianne D Jett, Gordon Kordas, Sara Parent, et al.
Alcohol, Clinical & Experimental Research|February 22, 2023
Validation of the quantification of phosphatidylethanol 16:0/18:1 concentrations in TASSO-M20 devicesJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.
The American Journal of Drug and Alcohol Abuse|January 29, 2024
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trialJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.
Journal of Consulting and Clinical Psychology|June 26, 2025
Testing adaptations to contingency management for alcohol use disorders: A randomized controlled trialMichael G McDonell, Sara Parent, Julianne D Jett, et al.
Drug and Alcohol Dependence Reports|October 21, 2024
Covid-19 vaccination status and beliefs of individuals with co-occurring serious mental illness and alcohol use disorderMohammad Keshtkar, Diana Tyutyunnyk, Paige King, et al.
Pageof 2